ANI Pharmaceuticals, Inc. (ANIP) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ani Pharmaceuticals, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.870 -- 00:00:05.694 Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. 00:00:05.694 -- 00:00:10.078 Fourth Quarter and Full Year 2025 Earnings Results Call. 00:00:10.078 -- 00:00:14.622 Please note this call is being recorded. After the speaker's prepared remarks, there 00:00:14.622 -- 00:00:18.546 will be a question and answer session. If you would like to ask a question during this 00:00:18.546 -- 00:00:23.491 time, simply press star, then the number one on your telephone keypad. 00:00:23.491 -- 00:00:27.955 If you would like to withdraw your question, please press the star key, then number two 00:00:27.955 -- 00:00:32.924 on your telephone keypad. It is now my pleasure to turn the conference over to Courtney 00:00:32.924 -- 00:00:36.005 Moberly. Please go ahead. 00:00:36.689 -- 00:00:42.677 Thank you, Erica. Welcome to A&I Pharmaceutical's fourth quarter and full year 2025 00:00:42.677 -- 00:00:48.325 earnings results call. This is Courtney Moberly, investor relations for A&I. 00:00:48.325 -- 00:00:53.491 With me on today's call are Nikhil Aulani, president and chief executive officer, 00:00:53.491 -- 00:00:58.616 Stephen Carey, Senior Vice President and Chief Financial Officer, and Chris Mutz, 00:00:58.616 -- 00:01:03.041 Senior Vice President and Head of ANI's Rare Disease Business. 00:01:03.041 -- 00:01:07.786 You can also access the webcast of this call through the Investors section of the ANI 00:01:07.786 -- 00:01:10.767 website at anifarmaceuticals.com. 00:01:11.290 -- 00:01:15.314 This call is accompanied by a slide deck that can be accessed by going to the Events 00:01:15.314 -- 00:01:19.016 section of the Investors page of our website. 00:01:19.599 -- 00:01:23.174 You can turn to our forward-looking statements on slide tw...